Agile Therapeutics, Inc. (AGRX)
OTCMKTS: AGRX · Delayed Price · USD
0.384
+0.014 (3.67%)
Apr 16, 2024, 2:14 PM EDT - Market open
Agile Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.59 | 10.88 | 4.1 | 0.75 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Revenue Growth (YoY) | 80.02% | 165.40% | 447.53% | - | - | - | - | - | - | - | Upgrade
|
| Cost of Revenue | 8.98 | 6.84 | 10.72 | 0.28 | 0.16 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Gross Profit | 10.62 | 4.05 | -6.62 | 0.47 | -0.16 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Selling, General & Admin | 28.27 | 42.23 | 58.14 | 36.02 | 9 | 8.74 | 12.38 | 8.79 | 7.47 | 5.15 | Upgrade
|
| Research & Development | 2.23 | 3.25 | 6.25 | 13.5 | 9.86 | 9.78 | 14.43 | 20.93 | 25.62 | 13.37 | Upgrade
|
| Other Operating Expenses | 0 | 4.29 | -5.3 | 0 | 0 | 1.02 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 30.5 | 45.48 | 64.39 | 49.52 | 18.86 | 18.52 | 26.81 | 29.72 | 33.09 | 18.52 | Upgrade
|
| Operating Income | -19.88 | -41.43 | -71.01 | -49.05 | -18.86 | -19.54 | -26.81 | -29.72 | -33.09 | -18.52 | Upgrade
|
| Interest Income | 0.08 | 0.08 | 0.03 | 0.31 | 0.25 | 0.37 | 0.28 | 0.12 | 0.01 | 0 | Upgrade
|
| Interest Expense | 1.42 | 3.13 | 3.91 | 3.11 | 0 | 1.12 | 1.92 | 2.33 | 2.07 | 1.56 | Upgrade
|
| Other Expense / Income | -8.18 | -14.4 | - | - | - | -0.03 | -2.06 | -0.12 | 1.15 | -0.35 | Upgrade
|
| Pretax Income | -14.47 | -30.09 | -74.89 | -51.85 | -18.61 | -20.26 | -28.3 | -31.82 | -36.31 | -19.73 | Upgrade
|
| Income Tax | 1.42 | -4.68 | 1.69 | 2.83 | -0.16 | -0.48 | 1.92 | -3.08 | -5.97 | -3.65 | Upgrade
|
| Net Income | -14.47 | -25.41 | -76.59 | -54.69 | -18.44 | -19.78 | -28.3 | -28.74 | -30.34 | -16.08 | Upgrade
|
| Shares Outstanding (Basic) | 2,157 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2,157 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change | 498890.32% | 35520.10% | -97.13% | 71.31% | 44.06% | 10.90% | 9.44% | 28.42% | 93.22% | 16.93% | Upgrade
|
| EPS (Basic) | -0.01 | -58.79 | -63115.49 | -1291.56 | -746.20 | -1152.82 | -1829.61 | -2033.18 | -2755.72 | -2822.01 | Upgrade
|
| EPS (Diluted) | -0.01 | -58.79 | -63115.49 | -1291.56 | -746.20 | -1152.82 | -1829.61 | -2033.18 | -2755.72 | -2822.01 | Upgrade
|
| Free Cash Flow | -9.58 | -36.08 | -65.47 | -47.66 | -15.79 | -17.21 | -25.87 | -23.33 | -25.77 | -14.6 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -83.48 | -53956.18 | -1125.72 | -638.74 | -1003.26 | -1672.46 | -1650.54 | -2340.84 | -2562.48 | Upgrade
|
| Gross Margin | 54.18% | 37.19% | -161.35% | 62.35% | - | - | - | - | - | - | Upgrade
|
| Operating Margin | -101.49% | -380.69% | -1731.41% | -6549.13% | - | - | - | - | - | - | Upgrade
|
| Profit Margin | -73.83% | -233.48% | -1867.47% | -7301.20% | - | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -48.88% | -331.50% | -1596.46% | -6363.68% | - | - | - | - | - | - | Upgrade
|
| EBITDA | -19.42 | -41.35 | -70.98 | -48.74 | -18.61 | -18.15 | -26.51 | -29.72 | -33.09 | -18.52 | Upgrade
|
| EBITDA Margin | -99.12% | -379.95% | -1730.80% | -6507.88% | - | - | - | - | - | - | Upgrade
|
| Depreciation & Amortization | 0.39 | 1.53 | 2.22 | 0.28 | 0.16 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| EBIT | -19.81 | -42.89 | -73.2 | -49.02 | -18.77 | -18.17 | -26.53 | -29.74 | -33.11 | -18.53 | Upgrade
|
| EBIT Margin | -101.09% | -394.05% | -1785.00% | -6544.73% | - | - | - | - | - | - | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.